{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:17:51Z","timestamp":1770682671032,"version":"3.49.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11549-9","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T05:25:14Z","timestamp":1770614714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomes as mediators of repair and immunoregulation in multiple sclerosis: a new frontier in cell-free therapy"],"prefix":"10.1007","volume":"53","author":[{"given":"Usamah","family":"Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baraa","family":"Mohammed Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Malathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashree","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Thyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Shankhyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasulbek","family":"Eshmetov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-8163","authenticated-orcid":false,"given":"Zokir","family":"Ataullaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar-Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"2","key":"11549_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cimb45020094","volume":"45","author":"G Papiri","year":"2023","unstructured":"Papiri G, D\u2019Andreamatteo G, Cacchi\u00f2 G, Alia S, Silvestrini M, Paci C et al (2023) Multiple sclerosis: inflammatory and neuroglial aspects. Curr Issues Mol Biol 45(2):1443\u201370","journal-title":"Curr Issues Mol Biol"},{"issue":"14","key":"11549_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 26(14):1816\u201321","journal-title":"Mult Scler"},{"key":"11549_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104927","volume":"78","author":"E Uygur-Kucukseymen","year":"2023","unstructured":"Uygur-Kucukseymen E, Pacheco-Barrios K, Yuksel B, Gonzalez-Mego P, Soysal A, Fregni F (2023) Non-invasive brain stimulation on clinical symptoms in multiple sclerosis patients: a systematic review and meta-analysis. Mult Scler Relat Disord 78:104927","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"11549_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","volume":"10","author":"I Boutitah-Benyaich","year":"2025","unstructured":"Boutitah-Benyaich I, Eixarch H, Villacieros-\u00c1lvarez J, Hervera A, Cobo-Calvo \u00c1, Montalban X et al (2025) Multiple sclerosis: molecular pathogenesis and therapeutic intervention. Signal Transduct Target Ther 10(1):324","journal-title":"Signal Transduct Target Ther"},{"key":"11549_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168370","author":"R Balasa","year":"2021","unstructured":"Balasa R, Barcutean L, Mosora O, Manu D (2021) Reviewing the significance of blood-brain barrier disruption in multiple sclerosis pathology and treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168370","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11549_CR6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s13311-021-01048-z","volume":"18","author":"ES Frisch","year":"2021","unstructured":"Frisch ES, Pretzsch R, Weber MS (2021) A milestone in multiple sclerosis therapy: monoclonal antibodies against CD20\u2014yet progress continues. Neurotherapeutics 18(3):1602\u20131622","journal-title":"Neurotherapeutics"},{"issue":"10","key":"11549_CR7","first-page":"e47972","volume":"15","author":"A Msheik","year":"2023","unstructured":"Msheik A, Assi F, Hamed F, Jibbawi A, Nakhl AM, Khoury A et al (2023) Stem cell transplantation for multiple sclerosis: A 2023 review of published studies. Cureus 15(10):e47972","journal-title":"Cureus"},{"key":"11549_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065","journal-title":"Front Neurosci"},{"issue":"1","key":"11549_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI (2019) Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med 4(1):22","journal-title":"NPJ Regen Med"},{"issue":"5","key":"11549_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","volume":"18","author":"D Jovic","year":"2022","unstructured":"Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F et al (2022) A brief overview of global trends in MSC-based cell therapy. Stem Cell Rev Rep 18(5):1525\u201345","journal-title":"Stem Cell Rev Rep"},{"key":"11549_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6726185","volume":"2018","author":"J Steens","year":"2018","unstructured":"Steens J, Klein D (2018) Current strategies to generate human mesenchymal stem cells in vitro. Stem Cells Int 2018:6726185","journal-title":"Stem Cells Int"},{"issue":"1","key":"11549_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L et al (2025) Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther 10(1):262","journal-title":"Signal Transduct Target Ther"},{"key":"11549_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms251910292","volume":"25","author":"T Kr\u00e5kenes","year":"2024","unstructured":"Kr\u00e5kenes T, Sandvik CE, Ytterdal M, Gavasso S, Evjenth EC, B\u00f8 L et al (2024) The therapeutic potential of exosomes from mesenchymal stem cells in multiple sclerosis. Int J Mol Sci 25:19","journal-title":"Int J Mol Sci"},{"key":"11549_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711362","volume":"12","author":"J He","year":"2021","unstructured":"He J, Huang Y, Liu J, Lan Z, Tang X, Hu Z (2021) The efficacy of mesenchymal stem cell therapies in rodent models of multiple sclerosis: an updated systematic review and meta-analysis. Front Immunol 12:711362","journal-title":"Front Immunol"},{"key":"11549_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.addr.2020.02.006","volume":"165\u2013166","author":"MJ Fowler","year":"2020","unstructured":"Fowler MJ, Cotter JD, Knight BE, Sevick-Muraca EM, Sandberg DI, Sirianni RW (2020) Intrathecal drug delivery in the era of nanomedicine. Adv Drug Deliv Rev 165\u2013166:77\u201395","journal-title":"Adv Drug Deliv Rev"},{"key":"11549_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02837","volume":"9","author":"JR Ferreira","year":"2018","unstructured":"Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gon\u00e7alves RM (2018) Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol 9:2837","journal-title":"Front Immunol"},{"key":"11549_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fcell.2025.1517369","volume":"13","author":"K Sheikhi","year":"2025","unstructured":"Sheikhi K, Ghaderi S, Firouzi H, Rahimibarghani S, Shabani E, Afkhami H et al (2025) Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges. Front Cell Dev Biology 13:2025","journal-title":"Front Cell Dev Biology"},{"issue":"6","key":"11549_CR18","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar M, Mohammadi MR, Pone EJ, Yeri A, L\u00e4sser C, Segaliny AI et al (2019) Stem Cell-Derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano 13(6):6670\u20136688","journal-title":"ACS Nano"},{"issue":"11","key":"11549_CR19","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov R, Sasso JM, Wang X, Liaw W-S, Chen C-A, Zhou QA (2022) ExosomesNature\u2019s lipid nanoparticles, a rising star in drug delivery and diagnostics. ACS Nano 16(11):17802\u201317846","journal-title":"ACS Nano"},{"key":"11549_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2025.112978","volume":"46","author":"Z-h Zhang","year":"2025","unstructured":"Zhang Z-h, Cao H-m, Li X (2025) Exosomes serve as molecular diagnostic biomarkers and carriers for tissue engineering applications. Mater Today Commun 46:112978","journal-title":"Mater Today Commun"},{"key":"11549_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"key":"11549_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. https:\/\/doi.org\/10.3390\/cells8070727","journal-title":"Cells"},{"key":"11549_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vesic.2024.100034","volume":"3","author":"Z Ding","year":"2024","unstructured":"Ding Z, Greenberg ZF, Serafim MF, Ali S, Jamieson JC, Traktuev DO et al (2024) Understanding molecular characteristics of extracellular vesicles derived from different types of mesenchymal stem cells for therapeutic translation. Extracellular Vesicle 3:100034","journal-title":"Extracellular Vesicle"},{"issue":"3","key":"11549_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10266-018-0395-9","volume":"107","author":"K Ren","year":"2019","unstructured":"Ren K (2019) Exosomes in perspective: a potential surrogate for stem cell therapy. Odontology 107(3):271\u2013284","journal-title":"Odontology"},{"key":"11549_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082042","author":"HB Koh","year":"2023","unstructured":"Koh HB, Kim HJ, Kang SW, Yoo TH (2023) Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15082042","journal-title":"Pharmaceutics"},{"issue":"1","key":"11549_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010255","volume":"25","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xiao T, Zhao C, Li G (2024) The regulation of exosome generation and function in physiological and pathological processes. Int J Mol Sci 25(1):255","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11549_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A (2018) Current knowledge on exosome biogenesis and release. Cell Mol Life Sci 75(2):193\u2013208","journal-title":"Cell Mol Life Sci"},{"key":"11549_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2017.08.020","volume":"74","author":"EB Frankel","year":"2018","unstructured":"Frankel EB, Audhya A (2018) ESCRT-dependent cargo sorting at multivesicular endosomes. Semin Cell Dev Biol 74:4\u201310","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"11549_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12060633","volume":"12","author":"Y Olmos","year":"2022","unstructured":"Olmos Y (2022) The ESCRT machinery: remodeling, repairing, and sealing membranes. Membranes 12(6):633","journal-title":"Membranes"},{"issue":"4","key":"11549_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104575","volume":"299","author":"N Jukic","year":"2023","unstructured":"Jukic N, Perrino AP, Redondo-Morata L, Scheuring S (2023) Structure and dynamics of ESCRT-III membrane remodeling proteins by high-speed atomic force microscopy. J Biol Chem 299(4):104575","journal-title":"J Biol Chem"},{"key":"11549_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315317","author":"R Horbay","year":"2022","unstructured":"Horbay R, Hamraghani A, Ermini L, Holcik S, Beug ST, Yeganeh B (2022) Role of ceramides and lysosomes in extracellular vesicle biogenesis, cargo sorting and release. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315317","journal-title":"Int J Mol Sci"},{"key":"11549_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207568","author":"J Jankovi\u010dov\u00e1","year":"2020","unstructured":"Jankovi\u010dov\u00e1 J, Se\u010dov\u00e1 P, Michalkov\u00e1 K, Antal\u00edkov\u00e1 J (2020) Tetraspanins, more than markers of extracellular vesicles in reproduction. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207568","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11549_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"Q-F Han","year":"2022","unstructured":"Han Q-F, Li W-J, Hu K-S, Gao J, Zhai W-L, Yang J-H et al (2022) Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 21(1):207","journal-title":"Mol Cancer"},{"issue":"4","key":"11549_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC (2024) Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med 56(4):877\u2013889","journal-title":"Exp Mol Med"},{"key":"11549_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vesic.2024.100049","volume":"4","author":"S Singh","year":"2024","unstructured":"Singh S, Chen CC, Kim S, Singh A, Singh G (2024) Role of extracellular vesicle microRNAs and RNA binding proteins on glioblastoma dynamics and therapeutics development. Extracellular Vesicle 4:100049","journal-title":"Extracellular Vesicle"},{"key":"11549_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna5010028","author":"H Schwarzenbach","year":"2019","unstructured":"Schwarzenbach H, Gahan PB (2019) MicroRNA shuttle from cell-to-cell by exosomes and its impact in cancer. Non-coding RNA. https:\/\/doi.org\/10.3390\/ncrna5010028","journal-title":"Non-coding RNA"},{"issue":"2","key":"11549_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya SB, Collie SP, Parent CA (2024) The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol 34(2):90\u2013108","journal-title":"Trends Cell Biol"},{"issue":"9","key":"11549_CR38","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac R, Reis FCG, Ying W, Olefsky JM (2021) Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab 33(9):1744\u20131762","journal-title":"Cell Metab"},{"issue":"5","key":"11549_CR39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/membranes12050498","volume":"12","author":"S Xie","year":"2022","unstructured":"Xie S, Zhang Q, Jiang L (2022) Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes 12(5):498","journal-title":"Membranes"},{"issue":"5","key":"11549_CR40","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.gendis.2022.03.021","volume":"10","author":"M Xu","year":"2023","unstructured":"Xu M, Ji J, Jin D, Wu Y, Wu T, Lin R et al (2023) The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases. Genes Dis 10(5):1894\u20131907","journal-title":"Genes Dis"},{"issue":"1","key":"11549_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19(1):47","journal-title":"Cell Commun Signal"},{"issue":"4","key":"11549_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213\u201328","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"11549_CR43","doi-asserted-by":"publisher","first-page":"R435","DOI":"10.1016\/j.cub.2018.01.059","volume":"28","author":"J Meldolesi","year":"2018","unstructured":"Meldolesi J (2018) Exosomes and ectosomes in intercellular communication. Curr Biol 28(8):R435\u2013R44","journal-title":"Curr Biol"},{"key":"11549_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081296","author":"I Prada","year":"2016","unstructured":"Prada I, Meldolesi J (2016) Binding and fusion of extracellular vesicles to the plasma membrane of their cell targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17081296","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11549_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031861","volume":"24","author":"H Mado","year":"2023","unstructured":"Mado H, Adamczyk-Sowa M, Sowa P (2023) Role of microglial cells in the pathophysiology of MS: synergistic or antagonistic? Int J Mol Sci 24(3):1861","journal-title":"Int J Mol Sci"},{"issue":"7","key":"11549_CR46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/glia.24148","volume":"70","author":"MK Sen","year":"2022","unstructured":"Sen MK, Mahns DA, Coorssen JR, Shortland PJ (2022) The roles of microglia and astrocytes in phagocytosis and myelination: insights from the Cuprizone model of multiple sclerosis. Glia 70(7):1215\u20131250","journal-title":"Glia"},{"issue":"1","key":"11549_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12974-024-03015-9","volume":"21","author":"EY Luo","year":"2024","unstructured":"Luo EY, Sugimura RR (2024) Taming microglia: the promise of engineered microglia in treating neurological diseases. J Neuroinflammation 21(1):19","journal-title":"J Neuroinflammation"},{"issue":"2","key":"11549_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00401-021-02384-2","volume":"143","author":"AG Spiteri","year":"2022","unstructured":"Spiteri AG, Wishart CL, Pamphlett R, Locatelli G, King NJC (2022) Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function. Acta Neuropathol 143(2):179\u2013224","journal-title":"Acta Neuropathol"},{"key":"11549_CR49","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16359","volume":"11","author":"X Huang","year":"2023","unstructured":"Huang X, Liu X, Zeng J, Du P, Huang X, Lin J (2023) Bone marrow mesenchymal stem cell-derived exosomal microRNA regulates microglial polarization. PeerJ 11:e16359","journal-title":"PeerJ"},{"key":"11549_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101694","volume":"183","author":"X Xia","year":"2019","unstructured":"Xia X, Wang Y, Huang Y, Zhang H, Lu H, Zheng JC (2019) Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents. Prog Neurobiol 183:101694","journal-title":"Prog Neurobiol"},{"key":"11549_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042406","author":"Y Morishima","year":"2024","unstructured":"Morishima Y, Kawabori M, Yamazaki K, Takamiya S, Yamaguchi S, Nakahara Y et al (2024) Intravenous administration of mesenchymal stem cell-derived exosome alleviates spinal cord injury by regulating neutrophil extracellular trap formation through exosomal miR-125a-3p. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25042406","journal-title":"Int J Mol Sci"},{"key":"11549_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132091","author":"MY Wendimu","year":"2022","unstructured":"Wendimu MY, Hooks SB (2022) Microglia phenotypes in aging and neurodegenerative diseases. Cells. https:\/\/doi.org\/10.3390\/cells11132091","journal-title":"Cells"},{"issue":"1","key":"11549_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03019-5","volume":"21","author":"XY Ji","year":"2024","unstructured":"Ji XY, Guo YX, Wang LB, Wu WC, Wang JQ, He J et al (2024) Microglia-derived exosomes modulate myelin regeneration via miR-615-5p\/MYRF axis. J Neuroinflammation 21(1):29","journal-title":"J Neuroinflammation"},{"issue":"3","key":"11549_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/svn-2020-000419","volume":"6","author":"Y Li","year":"2021","unstructured":"Li Y, Tang Y, Yang GY (2021) Therapeutic application of exosomes in ischaemic stroke. Stroke Vasc Neurol 6(3):483\u2013495","journal-title":"Stroke Vasc Neurol"},{"issue":"9","key":"11549_CR55","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","volume":"14","author":"EE Reza-Zaldivar","year":"2019","unstructured":"Reza-Zaldivar EE, Hern\u00e1ndez-Sapi\u00e9ns MA, Guti\u00e9rrez-Mercado YK, Sandoval-\u00c1vila S, Gomez-Pinedo U, M\u00e1rquez-Aguirre AL et al (2019) Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer\u2019s disease. Neural Regen Res 14(9):1626\u201334","journal-title":"Neural Regen Res"},{"key":"11549_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1017484","volume":"15","author":"N Saez-Calveras","year":"2022","unstructured":"Saez-Calveras N, Brewster AL, Stuve O (2022) The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: a review. Front Mol Neurosci 15:1017484","journal-title":"Front Mol Neurosci"},{"key":"11549_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li Z, Liu F, He X, Yang X, Shan F, Feng J (2019) Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. Int Immunopharmacol 67:268\u2013280","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"11549_CR58","doi-asserted-by":"publisher","first-page":"e0202590","DOI":"10.1371\/journal.pone.0202590","volume":"13","author":"F Laso-Garc\u00eda","year":"2018","unstructured":"Laso-Garc\u00eda F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, Feli\u00fa A, G\u00f3mez-de Frutos M et al (2018) Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis. PLoS ONE 13(9):e0202590","journal-title":"PLoS ONE"},{"key":"11549_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113895","volume":"347","author":"J Zhang","year":"2022","unstructured":"Zhang J, Buller BA, Zhang ZG, Zhang Y, Lu M, Rosene DL et al (2022) Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol 347:113895","journal-title":"Exp Neurol"},{"issue":"1","key":"11549_CR60","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1038\/s41598-018-25676-2","volume":"8","author":"A Farinazzo","year":"2018","unstructured":"Farinazzo A, Angiari S, Turano E, Bistaffa E, Dusi S, Ruggieri S et al (2018) Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis. Sci Rep 8(1):7473","journal-title":"Sci Rep"},{"issue":"1","key":"11549_CR61","doi-asserted-by":"publisher","first-page":"38743","DOI":"10.1038\/srep38743","volume":"6","author":"TS Rajan","year":"2016","unstructured":"Rajan TS, Giacoppo S, Diomede F, Ballerini P, Paolantonio M, Marchisio M et al (2016) The secretome of periodontal ligament stem cells from MS patients protects against EAE. Sci Rep 6(1):38743","journal-title":"Sci Rep"},{"issue":"11","key":"11549_CR62","doi-asserted-by":"publisher","first-page":"8779","DOI":"10.1002\/jcp.29721","volume":"235","author":"M Jafarinia","year":"2020","unstructured":"Jafarinia M, Alsahebfosoul F, Salehi H, Eskandari N, Azimzadeh M, Mahmoodi M et al (2020) Therapeutic effects of extracellular vesicles from human adipose-derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis. J Cell Physiol 235(11):8779\u20138790","journal-title":"J Cell Physiol"},{"issue":"1","key":"11549_CR63","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1038\/s41598-021-91291-3","volume":"11","author":"S Ahmadvand Koohsari","year":"2021","unstructured":"Ahmadvand Koohsari S, Absalan A, Azadi D (2021) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines. Sci Rep 11(1):11658","journal-title":"Sci Rep"},{"issue":"3","key":"11549_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0394632017722332","volume":"30","author":"T Soundara Rajan","year":"2017","unstructured":"Soundara Rajan T, Giacoppo S, Diomede F, Bramanti P, Trubiani O, Mazzon E (2017) Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis. Int J Immunopathol Pharmacol 30(3):238\u2013252","journal-title":"Int J Immunopathol Pharmacol"},{"key":"11549_CR65","doi-asserted-by":"publisher","first-page":"100623","DOI":"10.1016\/j.mtadv.2025.100623","volume":"28","author":"E Dikici","year":"2025","unstructured":"Dikici E, \u00d6nal Acet B, G\u00fcl D, Kummer N, Stauber RH, Odaba\u015f\u0131 M et al (2025) Bringing exosomes into the game: current situation, opportunities, limitations and future perspectives. Mater Today Adv 28:100623","journal-title":"Mater Today Adv"},{"issue":"1","key":"11549_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H (2023) Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther 14(1):66","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"11549_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4236\/cm.2020.113007","volume":"32","author":"YS Chen","year":"2020","unstructured":"Chen YS, Lin EY, Chiou TW, Harn HJ (2020) Exosomes in clinical trial and their production in compliance with good manufacturing practice. Tzu Chi Med J 32(2):113\u2013120","journal-title":"Tzu Chi Med J"},{"key":"11549_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-016-0068-0","volume":"20","author":"W Nassar","year":"2016","unstructured":"Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T, Kotb E et al (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20:21","journal-title":"Biomater Res"},{"issue":"12","key":"11549_CR69","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","volume":"29","author":"V Sengupta","year":"2020","unstructured":"Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N (2020) Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev 29(12):747\u2013754","journal-title":"Stem Cells Dev"},{"issue":"5","key":"11549_CR70","doi-asserted-by":"publisher","first-page":"e101143","DOI":"10.1136\/gpsych-2023-101143","volume":"36","author":"X Xie","year":"2023","unstructured":"Xie X, Song Q, Dai C, Cui S, Tang R, Li S et al (2023) Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatr 36(5):e101143","journal-title":"Gen Psychiatr"},{"issue":"1","key":"11549_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J (2024) Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther 9(1):17","journal-title":"Signal Transduct Target Ther"},{"key":"11549_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061283","author":"WM Pardridge","year":"2022","unstructured":"Pardridge WM (2022) A historical review of brain drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14061283","journal-title":"Pharmaceutics"},{"issue":"1","key":"11549_CR73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ca.24199","volume":"38","author":"L Johnsen","year":"2025","unstructured":"Johnsen L, Friis KA, M\u00f8ller-Madsen MK, Damkier HH (2025) Mechanisms of cerebrospinal fluid secretion by the choroid plexus epithelium: application to various intracranial pathologies. Clin Anat 38(1):63\u201374","journal-title":"Clin Anat"},{"issue":"1","key":"11549_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8(1):217","journal-title":"Signal Transduct Target Ther"},{"issue":"Pt B","key":"11549_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2018.06.006","volume":"145","author":"R Guennoun","year":"2019","unstructured":"Guennoun R, Fr\u00e9chou M, Gaignard P, Liere P, Slama A, Schumacher M et al (2019) Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries. Neuropharmacology 145(Pt B):283\u2013291","journal-title":"Neuropharmacology"},{"key":"11549_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1271489","volume":"11","author":"J Zhao","year":"2023","unstructured":"Zhao J, Yang J, Jiao J, Wang X, Zhao Y, Zhang L (2023) Biomedical applications of artificial exosomes for intranasal drug delivery. Front Bioeng Biotechnol 11:1271489","journal-title":"Front Bioeng Biotechnol"},{"key":"11549_CR77","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.neuint.2021.105173","volume":"150","author":"LD Moss","year":"2021","unstructured":"Moss LD, Sode D, Patel R, Lui A, Hudson C, Patel NA et al (2021) Intranasal delivery of exosomes from human adipose derived stem cells at forty-eight hours post injury reduces motor and cognitive impairments following traumatic brain injury. Neurochem Int 150:105173","journal-title":"Neurochem Int"},{"key":"11549_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112578","author":"W Shen","year":"2023","unstructured":"Shen W, You T, Xu W, Xie Y, Wang Y, Cui M (2023) Rapid and widespread distribution of intranasal small extracellular vesicles derived from mesenchymal stem cells throughout the brain potentially via the perivascular pathway. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15112578","journal-title":"Pharmaceutics"},{"key":"11549_CR79","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jconrel.2023.01.073","volume":"355","author":"B Lorenzini","year":"2023","unstructured":"Lorenzini B, Peltzer J, Goulinet S, Rival B, Lataillade J-J, Uzan G et al (2023) Producing vesicle-free cell culture additive for human cells extracellular vesicles manufacturing. J Control Release 355:501\u201314","journal-title":"J Control Release"},{"issue":"1","key":"11549_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04341-2","volume":"16","author":"C Ulpiano","year":"2025","unstructured":"Ulpiano C, Salvador W, Franchi-Mendes T, Huang M-C, Lin Y-H, Lin H-T et al (2025) Continuous collection of human mesenchymal-stromal-cell-derived extracellular vesicles from a stirred tank reactor operated under xenogeneic-free conditions for therapeutic applications. Stem Cell Res Ther 16(1):210","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"11549_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13770-021-00352-1","volume":"18","author":"JY Kim","year":"2021","unstructured":"Kim JY, Rhim WK, Seo HJ, Lee JY, Park CG, Han DK (2021) Comparative analysis of MSC-derived exosomes depending on cell culture media for regenerative bioactivity. Tissue Eng Regen Med 18(3):355\u2013367","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"11549_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-03122-5","volume":"13","author":"H Yari","year":"2022","unstructured":"Yari H, Mikhailova MV, Mardasi M, Jafarzadehgharehziaaddin M, Shahrokh S, Thangavelu L et al (2022) Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach. Stem Cell Res Ther 13(1):423","journal-title":"Stem Cell Res Ther"},{"key":"11549_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"key":"11549_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/cells14151172","author":"B Rossi","year":"2025","unstructured":"Rossi B, Virla F, Angelini G, Scambi I, Bani A, Marostica G et al (2025) Intranasal administration of extracellular vesicles derived from adipose mesenchymal stem cells has therapeutic effect in experimental autoimmune encephalomyelitis. Cells. https:\/\/doi.org\/10.3390\/cells14151172","journal-title":"Cells"},{"key":"11549_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.863364","volume":"10","author":"J Sun","year":"2022","unstructured":"Sun J, Wang Z, Liu P, Hu Y, Li T, Yang J et al (2022) Exosomes derived from human gingival mesenchymal stem cells attenuate the inflammatory response in periodontal ligament stem cells. Front Chem 10:863364","journal-title":"Front Chem"},{"key":"11549_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972247","volume":"13","author":"C Xun","year":"2022","unstructured":"Xun C, Deng H, Zhao J, Ge L, Hu Z (2022) Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: a meta-analysis. Front Immunol 13:972247","journal-title":"Front Immunol"},{"issue":"7","key":"11549_CR87","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11010-024-05051-8","volume":"479","author":"SH Hamidi","year":"2024","unstructured":"Hamidi SH, Etebar N, Rahimzadegan M, Zali A, Roodsari SR, Niknazar S (2024) Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice. Mol Cell Biochem 479(7):1643\u20131671","journal-title":"Mol Cell Biochem"},{"key":"11549_CR88","unstructured":"Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis (NCT07146087) (2025) [Available from: clinicaltrials.gov\/study\/NCT07146087"},{"key":"11549_CR89","doi-asserted-by":"crossref","unstructured":"Mohammad Jafari A, Sadegi K, Kaveh M, Zandi Mehran Y, Weber M, Golestanha SA et al (2025) Combined intrathecal and intravenous exosome injection efficiency in a multiple sclerosis patient: a case report: intrathecal and IV exosomes in MS: case report. Cell Mol Biol. 71(11)","DOI":"10.14715\/cmb\/2025.71.11.11"},{"key":"11549_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1349050","volume":"12","author":"Y Li","year":"2024","unstructured":"Li Y, Yue G, Yu S, Cheng X, Cao Y, Wang X (2024) Evaluating the efficacy of mesenchymal stem cells for diabetic neuropathy: a systematic review and meta-analysis of preclinical studies. Front Bioeng Biotechnol 12:1349050","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"11549_CR91","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2174\/1570159X21666230216095938","volume":"21","author":"Q Qu","year":"2023","unstructured":"Qu Q, Fu B, Long Y, Liu ZY, Tian XH (2023) Current strategies for promoting the Large-scale production of exosomes. Curr Neuropharmacol 21(9):1964\u20131979","journal-title":"Curr Neuropharmacol"},{"issue":"45","key":"11549_CR92","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1039\/D3CC01753B","volume":"59","author":"M Ghasemi","year":"2023","unstructured":"Ghasemi M, Rahimi B, Dehghan M, Bernoosha MH, Jafarpour F (2023) Syn-versus anti-carbopalladation of alkynes with organoborons: access to indoles symmetrically and unsymmetrically substituted on their 2, 3-positions. Chem Commun 59(45):6873\u20136876","journal-title":"Chem Commun"},{"key":"11549_CR93","doi-asserted-by":"crossref","unstructured":"Shao M, Rahmdel M, Shayan SK, Hassannia E, Khedmatgozar M, Yousefi K, Ali-Khiavi P, Hjazi A, Al-Aouadi RF, Sarvestani PA, Fard MR (2025) Advancements in biomaterials for stem cell differentiation. Stem Cell Reviews Rep 21:1\u20132","DOI":"10.1007\/s12015-025-10879-8"},{"issue":"9","key":"11549_CR94","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/1545968318798955","volume":"32","author":"L Qing","year":"2018","unstructured":"Qing L, Chen H, Tang J, Jia X (2018) Exosomes and their MicroRNA cargo: new players in peripheral nerve regeneration. Neurorehabil Neural Repair 32(9):765\u2013776","journal-title":"Neurorehabil Neural Repair"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11549-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:03:12Z","timestamp":1770620592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11549-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11549"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11549-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"373"}}